Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2005
[Malignant melanoma -- a medical students' viewpoint]Moritz Felcht, Jens Christian Fischer, Martin Michels, et al.
The Journal of Organic Chemistry|November 5, 2005
Efficient regioselective synthesis of 6-amino-5-benzoyl-1-substituted 2(1H)-pyridinonesHartmut Schirok, Cristina Alonso-Alija, Jordi Benet-Buchholz, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 26, 2003
Spiroconjugation in spirodicorrolato-dinickel(II)Georg Hohlneicher, Dominik Bremm, Jennifer Wytko, et al.
Cancer Letters|January 4, 2017
BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activitySusann Santag, Franziska Siegel, Antje M Wengner, et al.
Cancer Medicine|January 10, 2014
BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex IPeter Ellinghaus, Iring Heisler, Kerstin Unterschemmann, et al.
International Journal of Cancer|October 5, 2016
BAY 1125976, a selective allosteric AKT1/2 inhibitor, exhibits high efficacy on AKT signaling-dependent tumor growth in mouse modelsOliver Politz, Franziska Siegel, Lars Bärfacker, et al.
Molecular Cancer Therapeutics|February 3, 2016
Novel Mps1 Kinase Inhibitors with Potent Antitumor ActivityAntje M Wengner, Gerhard Siemeister, Marcus Koppitz, et al.
Chemmedchem|June 17, 2016
Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946)William J Scott, Martin F Hentemann, R Bruce Rowley, et al.
Journal of Medicinal Chemistry|September 25, 2007
Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesityJoachim Rudolph, William P Esler, Stephen O'connor, et al.
Pageof 1